Lee E M, Shapiro L M, Wells F C
Regional Cardiac Unit, Papworth Hospital, Cambridge, UK.
Circulation. 1996 Nov 1;94(9):2117-23. doi: 10.1161/01.cir.94.9.2117.
Mitral valve replacement (MVR) has a high mortality and morbidity. It has been suggested that preservation of the subvalvular apparatus and more optimal timing of surgery might improve outcome.
We performed a retrospective study of 612 consecutive patients who underwent mitral valve repair or replacement: 226 patients had repair, 68 had replacement with subvalvular preservation (MVR/SVP), and 318 had replacement without subvalvular preservation (MVR/NoSVP). Baseline characteristics were most unfavorable in the repair group with respect to age (P = .002) and in the repair and MVR/SVP groups with respect to NYHA functional class and left ventricular function (P = .044). Thirty-day mortality was lower in the repair (1.8%, P = .046) and MVR/SVP (1.5%. P = NS) groups than the MVR/NoSVP group (5.0%). Overall survival at 7 years was better in the repair (71.2 +/- 5.6%. P = .022) and MVR/SVP (66.2 +/- 12.4%, P = .017) groups than the MVR/NoSVP group (63.5 +/- 3.4%). Myocardial failure caused 66 of 107 complication-related deaths. Multivariate analysis confirmed independent beneficial effects of repair on 30-day mortality (odds ratio, 0.27, P < .05) and of repair and MVR/SVP on overall mortality (hazard ratios, 0.43, P < .001 and 0.40, P < .05, respectively) and complication-related death hazard ratios, 0.38, P < .001 and 0.35, P < .05, respectively). Preoperative NYHA class III or IV symptoms and left ventricular impairment were independent risk factors for death and myocardial failure.
Mitral valve repair is superior to replacement. If repair is not feasible, the subvalvular apparatus should be preserved. Early surgery before the development of severe symptoms and demonstrable left ventricular impairment is also needed to optimize outcome.
二尖瓣置换术(MVR)具有较高的死亡率和发病率。有人提出保留瓣下结构以及更优化的手术时机可能会改善手术效果。
我们对612例连续接受二尖瓣修复或置换术的患者进行了一项回顾性研究:226例患者接受了修复术,68例进行了保留瓣下结构的置换术(MVR/SVP),318例进行了未保留瓣下结构的置换术(MVR/NoSVP)。在年龄方面,修复组的基线特征最不理想(P = 0.002);在纽约心脏协会(NYHA)功能分级和左心室功能方面,修复组和MVR/SVP组的基线特征最不理想(P = 0.044)。修复组(1.8%,P = 0.046)和MVR/SVP组(1.5%,P = 无显著性差异)的30天死亡率低于MVR/NoSVP组(5.0%)。修复组(71.2±5.6%,P = 0.022)和MVR/SVP组(66.2±12.4%,P = 0.017)的7年总生存率高于MVR/NoSVP组(63.5±3.4%)。107例与并发症相关的死亡中,66例由心肌衰竭导致。多因素分析证实修复术对30天死亡率具有独立的有益影响(优势比,0.27,P < 0.05),修复术和MVR/SVP对总死亡率(风险比,分别为0.43,P < 0.001和0.40,P < 0.05)以及与并发症相关的死亡风险比(分别为0.38,P < 0.001和0.35,P < 0.05)具有独立的有益影响。术前NYHA III或IV级症状以及左心室功能损害是死亡和心肌衰竭的独立危险因素。
二尖瓣修复术优于置换术。如果修复不可行,应保留瓣下结构。还需要在出现严重症状和明显左心室功能损害之前尽早进行手术,以优化手术效果。